Walvax沃森生物

CN
EN

00

-0.22 (-0.6%)

Stock Code: 300142

Key Facts

5.3 billion

USD 5.3 billion market capitalization

706.4 million

USD 706.4 million revenue in 2022

152.7 million

USD 152.7 million operating profit in 2022

70.4%

70.4% increase in net profit attributable to Company owners in 2022

480.9 million

USD 480.9 million revenue in 2021

98.7 million

USD 98.7 million operating profit in 2021
Financial Reports
2023.08.28
2023 Interim Report
Download
2023.04.24
2023 First-Quarter Report
Download
2023.04.03
2022 Annual Report
Download
2022.08.11
2022 Interim Report
Download
2022.03.21
2021 Annual Report
Download
2021.03.21
2020 Annual Report
Download
2020.03.21
2019 Annual Report
Download